Oxford Nanopore Technologies Ltd is developing the GridION system, a new generation of technology that uses nanopores for the direct, electronic analysis of single molecules including DNA, RNA, proteins and other molecules. GridION has broad applications including scientific research, personalised medicine, crop science and security/defence.
The GridION system is designed to translate the key property of nanopore sensing (real-time, electronic analyses of single molecules) into an intelligent system with a new range of scientific and workflow benefits. Delivering analyses in real-time, experiments on the GridION system can be Run Until... the user's biological question is answered. Based on standard semiconductor technology, each instrument in a GridION system is networked; the system is highly scalable for use by any user from individual researchers to large installations.
With a broad patent portfolio, Oxford Nanopore's pipeline includes biological nanopores and solid-state nanopores for further improvements in speed and cost.
NEWS
-
Oxford Nanopore congratulates collaborator Professor Mark Akeson on $3.6 million NHGRI grant.
23 August 2011
- award to Professor Mark Akeson and collaborators will support research into DNA ‘Strand Sequencing’ using a protein nanopore -
Oxford Nanopore Technologies Ltd. is pleased to congratulate Professor Mark Akeson (University of California, Santa Cruz) and his collaborators on the award of a $3.6 million, three year grant by the National Human Genome Research Institute (NHGRI).
Professor Akeson h....
Read more...
-
Oxford Nanopore expands Oxford headquarters and opens new informatics outstation in Cambridge, UK
21 July 2011
Oxford Nanopore Technologies, Ltd announces the expansion of its Oxford headquarters and the opening of a new Oxford Nanopore informatics outstation in Cambridge, UK.
These new premises will support further corporate development of Oxford Nanopore following its recent £25 million fundraising. New space at Florey House, Oxford Science Park, adds to existing laboratories and offices at Edmund Cartwright House, expanding the Com....
Read more...
-
Oxford Nanopore appoints Peter Allen as Non-Executive Director
27 June 2011
Oxford Nanopore Technologies Ltd is pleased to announce the appointment of Peter Allen ACA to its board.
Peter Allen joins the board of Oxford Nanopore as non executive Director with broad, senior experience in the life sciences industries. He currently serves as Non-Executive Chairman on the Boards of ProStrakan Group plc, Chroma Therapeutics Ltd and Proximagen Neuroscience plc.
Previously, Peter was Chief Financial Offic....
Read more...
Subscribe to news alerts
